Back to Search
JENNIE BYRD, M.D.
M.D.
Physical Medicine & Rehabilitation Physician
NPI: 1306891668Individual
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
C40889(CA)
Research & Publications (20)
Prospective analysis of hip arthroscopy with 10-year followup.
PMID 19381742·Clin Orthop Relat Res·2010
8-other
Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.
PMID 18025295·Hypertension·2008
8-other
Phase 1 study of lumiliximab with detailed pharmacokinetic and pharmacodynamic measurements in patients with relapsed or refractory chronic lymphocytic leukemia.
PMID 17671129·Clin Cancer Res·2007
3-trial
Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.
PMID 16616068·Semin Oncol·2006
6-review
Tailored terahertz pulses from a laser-modulated electron beam.
PMID 16712239·Phys Rev Lett·2006
8-other
Angiotensin-converting enzyme inhibitor-associated angioedema.
PMID 17085287·Immunol Allergy Clin North Am·2006
6-review
Laser seeding of the storage-ring microbunching instability for high-power coherent terahertz radiation.
PMID 17026236·Phys Rev Lett·2006
8-other
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.
PMID 15020610·J Clin Oncol·2004
3-trial
Observation of broadband self-amplified spontaneous coherent terahertz synchrotron radiation in a storage ring.
PMID 12485072·Phys Rev Lett·2002
8-other
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).
PMID 12393746·Blood·2002
3-trial
UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism.
PMID 11378265·Exp Hematol·2001
7-preclinical
Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity.
PMID 11304767·J Clin Oncol·2001
3-trial
Novel therapies for chronic lymphocytic leukemia in the 21st century.
PMID 11049025·Semin Oncol·2000
6-review
Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders.
PMID 10877050·Semin Oncol·2000
8-other
Inhibition of gastric mucin synthesis by Helicobacter pylori.
PMID 10833482·Gastroenterology·2000
8-other
Dimerization of the insulin-like growth factor II/mannose 6-phosphate receptor.
PMID 10764761·J Biol Chem·2000
7-preclinical
Mechanisms for high affinity mannose 6-phosphate ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor.
PMID 10764735·J Biol Chem·2000
8-other
Mechanism of the block to hybridization and selfing between the sympatric ascidians Ciona intestinalis and Ciona savignyi.
PMID 10602281·Mol Reprod Dev·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2150 APPIAN WAY, 100
PINOLE, CA 94564 - Phone
- (707) 751-0878
Quick Facts
- NPI
- 1306891668
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile